Clindamycin Phosphate; Tretinoin Patent Expiration
Clindamycin Phosphate; Tretinoin is Used for managing symptoms and inflammation associated with atopic dermatitis. It was first introduced by Bausch Health Us Llc
Clindamycin Phosphate; Tretinoin Patents
Given below is the list of patents protecting Clindamycin Phosphate; Tretinoin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Veltin | US9492384 | Microemulsion and sub-micron emulsion process and compositions | Aug 31, 2025 | Almirall |
| Ziana | US6387383 | Topical low-viscosity gel composition |
Aug 03, 2020
(Expired) | Bausch |
| Ziana | USRE41134 | Slow release vehicles for minimizing skin irritancy of topical compositions |
Feb 24, 2015
(Expired) | Bausch |
| Veltin | US5690923 | Stable topical retinoid compositions |
Nov 25, 2014
(Expired) | Almirall |
A patent's expiry date may change depending upon legal activities going on that patent. Critical
activities like
abandoning of a patent, term extension of a patent or amendment of its claims can increase or
decrease the life of a
patent hence affecting its expiry date and in turn affecting the generic launch date of that
drug. Tracking these
ongoing activities on a patent application helps to keep an eye on the latest developments in
the patent process of
the drug which can give an idea of how early a drug's generic could be available. The next
section provides a list
of recent legal activities on Clindamycin Phosphate; Tretinoin's patents.
Latest Legal Activities on Clindamycin Phosphate; Tretinoin's Patents
Given below is the list recent legal activities going on the following patents of Clindamycin Phosphate; Tretinoin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 18 Apr, 2024 | US9492384 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 15 Apr, 2020 | US9492384 |
| Patent Issue Date Used in PTA Calculation Critical
| 15 Nov, 2016 | US9492384 |
| Recordation of Patent Grant Mailed Critical
| 15 Nov, 2016 | US9492384 |
| Email Notification Critical
| 27 Oct, 2016 | US9492384 |
| Issue Notification Mailed Critical
| 26 Oct, 2016 | US9492384 |
| Dispatch to FDC | 17 Oct, 2016 | US9492384 |
| Application Is Considered Ready for Issue Critical
| 14 Oct, 2016 | US9492384 |
| Issue Fee Payment Received Critical
| 13 Oct, 2016 | US9492384 |
| Issue Fee Payment Verified Critical
| 13 Oct, 2016 | US9492384 |
Clindamycin Phosphate; Tretinoin's Family Patents
